Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Dose Intranasal Oxytocin (IN-OT) Versus Placebo in Autism: Examining Cognitive Effects

NCT02493426 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT02493426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02493426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Dose Intranasal Oxytocin (IN-OT) Versus Placebo in Autism: Examining Cognitive Effects
Lead sponsor
University of Minnesota
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2014
Completion date
March 31, 2021
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorders